Leading the Way in Life Science Technologies

GEN Exclusives

More »


More »


  • Telormedix
  • Via dela Posta 10
  • Bioggio , CH-6934

Telormedix is a biopharmaceutical company focused on targeted immunity and the role of the innate immune system in treating cancer and autoimmune diseases. The company’s lead product, TMX-101, proved to have a good safety profile in humans during the first stage of a Phase I/II clinical trial for the localised treatment of Non-Muscle Invasive Bladder Cancer (NMIBC).

Related To This Company